Skip to main content

Cancer Moonshot℠ - Funding by Research Category

To ensure the Cancer Moonshot goals and approaches were grounded in the best science, NCI convened a Blue Ribbon Panel (BRP) of scientific experts as a working group to the National Cancer Advisory board. In September of 2016, the BRP presented a final report outlining 10 research recommendations that represent areas that are well-positioned to accelerate progress in cancer prevention, diagnosis, treatment and care.

Download Table Data

The following research categories align with these 10 recommendations:

Cancer Moonshot by Category, FY 2018
(Whole Dollars)
Research Category Amount
Network for Direct Patient Engagement     $864,531
Cancer Immunotherapy Translational Science Network     $67,643,470
Therapeutic Target Identification to Overcome Drug Resistance    


A National Cancer Data Ecosystem for Sharing and Analysis    


Fusion Oncoproteins in Childhood Cancers    


Minimize Cancer Treatment’s Debilitating Side Effects


Prevention and early detection: Implementation of Evidence-Based Approaches


Retrospective Analysis of Biospecimens form Patients Treated with Standard of Care


Generation of Human Tumor Atlases


Development of New Enabling Cancer Technologies


Other Cancer Moonshot priority activities (e.g., Partnership for Accelerating Cancer Therapies)


Total $305,112,172
 Includes FY 2017 Cures-Moonshot Carryover obligations.


  • Posted: